Annual Cash & Cash Equivalents
$405.73 M
+$403.86 M+21573.72%
December 31, 2023
Summary
- As of February 8, 2025, CRGX annual cash & cash equivalents is $405.73 million, with the most recent change of +$403.86 million (+21573.72%) on December 31, 2023.
- During the last 3 years, CRGX annual cash & cash equivalents has risen by +$405.69 million (+989490.24%).
- CRGX annual cash & cash equivalents is now at all-time high.
Performance
CRGX Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$71.18 M
-$82.41 M-53.66%
September 30, 2024
Summary
- As of February 8, 2025, CRGX quarterly cash and cash equivalents is $71.18 million, with the most recent change of -$82.41 million (-53.66%) on September 30, 2024.
- Over the past year, CRGX quarterly cash and cash equivalents has increased by +$10.83 million (+17.95%).
- CRGX quarterly cash and cash equivalents is now -82.46% below its all-time high of $405.73 million, reached on December 31, 2023.
Performance
CRGX Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
CRGX Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +10000.0% | +17.9% |
| 3 y3 years | +10000.0% | +3702.1% |
| 5 y5 years | +10000.0% | +3702.1% |
CRGX Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | >+9999.0% | -82.5% | +3702.1% |
| 5 y | 5-year | at high | >+9999.0% | -82.5% | +3702.1% |
| alltime | all time | at high | >+9999.0% | -82.5% | +3702.1% |
CARGO Therapeutics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $71.18 M(-53.7%) |
| Jun 2024 | - | $153.58 M(+88.4%) |
| Mar 2024 | - | $81.53 M(-79.9%) |
| Dec 2023 | $405.73 M | $405.73 M(+572.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | $60.34 M(+42.4%) |
| Jun 2023 | - | $42.37 M(+2163.4%) |
| Dec 2022 | $1.87 M(+4465.9%) | $1.87 M |
| Dec 2021 | $41.00 K | - |
FAQ
- What is CARGO Therapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for CARGO Therapeutics?
- What is CARGO Therapeutics annual cash & cash equivalents year-on-year change?
- What is CARGO Therapeutics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for CARGO Therapeutics?
- What is CARGO Therapeutics quarterly cash and cash equivalents year-on-year change?
What is CARGO Therapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of CRGX is $405.73 M
What is the all time high annual cash & cash equivalents for CARGO Therapeutics?
CARGO Therapeutics all-time high annual cash & cash equivalents is $405.73 M
What is CARGO Therapeutics annual cash & cash equivalents year-on-year change?
Over the past year, CRGX annual cash & cash equivalents has changed by +$403.86 M (+21573.72%)
What is CARGO Therapeutics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of CRGX is $71.18 M
What is the all time high quarterly cash and cash equivalents for CARGO Therapeutics?
CARGO Therapeutics all-time high quarterly cash and cash equivalents is $405.73 M
What is CARGO Therapeutics quarterly cash and cash equivalents year-on-year change?
Over the past year, CRGX quarterly cash and cash equivalents has changed by +$10.83 M (+17.95%)